Home / Resource Library / Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma

Results of a study examining zanubrutinib for the treatment of relapsed MCL.